Abstract: Provided are a novel fluorene derivative compound, and use thereof in preventing or treating metabolic diseases and/or cancer diseases through the action thereof as a PDK4 inhibitor.
Type:
Application
Filed:
July 28, 2023
Publication date:
November 5, 2026
Applicant:
JD BIOSCIENCE INC.
Inventors:
Haushabhau Shivaji PAGIRE, In Kyu LEE, Jae-Han JEON, Suvarna Haushabhau PAGIRE, Pyeong Keun KIM, Chang Joo OH, Yong Hyun JEON, Kwang Hee SON, Jin Hee AHN
Abstract: A compound of the present invention, which is a tricyclic derivative represented by chemical formula 1 or a pharmaceutically acceptable salt thereof, has an excellent inhibitory effect on serotonin activity and a pharmaceutical composition comprising same can be thus advantageously used for preventing or treating a metabolic disease associated with serotonin activation, etc.
Type:
Grant
Filed:
October 30, 2020
Date of Patent:
June 23, 2026
Assignee:
JD BIOSCIENCE INC.
Inventors:
Haushabhau Shivaji Pagire, Suvarna Haushabhau Pagire, Min Hee Kim, Won Mi Lee, Jin Hee Ahn, Sung Min Song, Heejong Lee, Dooseop Kim, Eun Young Lee
Abstract: A compound of the present invention, which is a tricyclic derivative represented by chemical formula 1 or a pharmaceutically acceptable salt thereof, has an excellent inhibitory effect on serotonin activity and a pharmaceutical composition comprising same can be thus advantageously used for preventing or treating a metabolic disease associated with serotonin activation, etc.
Type:
Application
Filed:
October 30, 2020
Publication date:
January 5, 2023
Applicant:
JD BIOSCIENCE INC.
Inventors:
Haushabhau Shivaji PAGIRE, Suvarna Haushabhau PAGIRE, Min Hee KIM, Won Mi LEE, Jin Hee AHN, Sung Min SONG, Heejong LEE, Dooseop KIM, Eun Young LEE